While Altimmune Inc has overperformed by 3.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALT rose by 180.06%, with highs and lows ranging from $14.84 to $3.16, whereas the simple moving average jumped by 17.10% in the last 200 days.
On November 12, 2024, UBS started tracking Altimmune Inc (NASDAQ: ALT) recommending Buy. A report published by Guggenheim on April 29, 2024, Downgraded its rating to ‘Neutral’ for ALT. Goldman also rated ALT shares as ‘Neutral’, setting a target price of $13 on the company’s shares in an initiating report dated January 24, 2024. Goldman March 22, 2023d the rating to Neutral on March 22, 2023, and set its price target from $20 to $6. Goldman initiated its ‘Buy’ rating for ALT, as published in its report on December 01, 2022. Jefferies’s report from December 29, 2021 suggests a price prediction of $30 for ALT shares, giving the stock a ‘Buy’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Altimmune Inc (ALT)
Further, the quarter-over-quarter decrease in sales is -98.62%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Altimmune Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -72.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 16.87, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 2.76M can be a very valuable indicator of volatility for ALT stock. On a monthly basis, the volatility of the stock is set at 10.56%, whereas on a weekly basis, it is put at 7.08%, with a gain of 1.96% over the past seven days. Furthermore, long-term investors anticipate a median target price of $21.25, showing growth from the present price of $8.85, which can serve as yet another indication of whether ALT is worth investing in or should be passed over.
How Do You Analyze Altimmune Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.83%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 56.16% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ALT shares are owned by institutional investors to the tune of 56.16% at present.
